Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

As Patient Benefits Become Clear, Multi-Drug Delivery Systems Gain Momentum

Greystone Associates
Posted on: 28 Jan 05

New Survey by Greystone Associates Examines Technology and Therapeutic Factors


“As clinical data reinforces the value of multi-drug protocols for the treatment of refractory conditions such as cancer and HIV, drug developers and pharmaceutical strategists are taking a harder look at technology for delivering two or more drugs in the same dosage form factor at different, and sometimes variable, rate profiles,” explains George Perros, Greystone Managing Director. “The availability of multiple drugs in a single delivery system simplifies administration and improves compliance, further benefiting outcomes.”

While interest in multi-drug delivery systems is growing across several therapeutic applications, an area of significant potential is in therapeutic drug combinations for HIV, a disease where the religious administration of multiple drugs is deemed critical to therapeutic outcomes. Chemotherapeutic ‘cocktails’ for various cancers are also strong candidates for multi-drug delivery technology.

These survey findings are contained in a new and comprehensive report: Multi-Drug Delivery Systems: Emerging Therapeutics and Opportunities The report contains a comprehensive assessment of multi-drug delivery technology, and provides an assessment of current and probably future multi-drug combination products, profiles of market participants, industry data and forecasts, and detailed analysis of regulatory and market factors. Organized and written to be of maximum value to pharmaceutical industry decision makers, delivery technology developers, and industry strategists, the report provides a detailed analysis of the growing potential for multi-drug delivery systems in disease therapeutics.

More information is available at .


 About Greystone


Greystone Associates is a medical and healthcare technology consulting firm providing services in strategic planning, venture development, product commercialization, and technology and market assessment.




Mark Smith

Voice: 603-595-4340

Fax: 603-804-0466                                         Source: Greystone Associates


For more information:

Editor's Details

Mark Smith
Greystone Associates

Last updated on: 27/08/2010

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.